Although NAFLD primarily affects patients with metabolic syndrome, obesity, and diabetes, recognizing classical risk factors such as obesity, renin–angiotensin system activation (RAS), fructose metabolism dysregulation, and lipogenesis in the development of both disorders, evidence considers inflammatory disorder the principal mechanism involved [34]. This evidence concerns the gene REN and obesity due to melanocortin 4 receptor deficiency.